Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis

Clicks: 487
ID: 112964
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #9 of 105 articles by views in Antimicrobial agents and chemotherapy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
We studied 122 stool samples collected from 25 patients with hematologic malignancies who received prophylactic norfloxacin. Fecal samples were obtained at admission and twice weekly thereafter during prophylaxis. Fluoroquinolone-resistant Escherichia coli strains were isolated from the feces of 10 …
Reference Key
j1996antimicrobialemergence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Carratala J;Fernandez-Sevilla A;Tubau F;Dominguez MA;Gudiol F;;
Journal Antimicrobial agents and chemotherapy
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8834911
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE gel humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male adolescent aged middle aged Comparative Study DNA Bacterial / analysis Feces / microbiology* drug resistance acute disease electrophoresis pulsed-field escherichia coli / drug effects* microbial / genetics neoplasms / microbiology j carratalà f gudiol anti-infective agents / therapeutic use* pmid:8834911 pmc163147 doi:10.1128/aac.40.2.503 a fernandez-sevilla anti-infective agents / pharmacology escherichia coli / genetics leukemia / drug therapy lymphoma / drug therapy multiple myeloma / drug therapy neoplasms / drug therapy* norfloxacin / therapeutic use* opportunistic infections / prevention & control*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.